Cargando…
Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
Autores principales: | Landauer, Karlheinz, Unutmaz, Cuneyt, Egli, Simon, Berger, Verena, Lais, Simone, Liebig, Timo, Steiner, Daniel, Maier, Jo, Rostalski, Ina, Forcellino, Francois, Herrmann, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284948/ https://www.ncbi.nlm.nih.gov/pubmed/22373224 http://dx.doi.org/10.1186/1753-6561-5-S8-P42 |
Ejemplares similares
-
Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
por: Richter, Fabian, et al.
Publicado: (2013) -
Cell line development using the SEFEX system
por: Greulich, Benedikt, et al.
Publicado: (2011) -
A platform fed-batch process for various CEMAX(®) producer cell lines
por: Greulich, Benedikt, et al.
Publicado: (2011) -
Development of a chemically defined CHO medium by engineering based on a feed solution
por: Landauer, Karlheinz, et al.
Publicado: (2011) -
Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
por: Siegmund, Daniela, et al.
Publicado: (2016)